, five patients (17.2%) had liver biopsy findings compatible with NASH, three (10.3%) with hepatic sarcoidosis, and in two patients, the liver histology disclosed congenital hepatic fibrosis, and non-specific findings were found in six (21%) patients [27]
Protein entries were first mapped to their human gene name orthologs and used as input for the enrichment analysis
Malignant peripheral nerve sheath tumors: a single institutions experience using combined surgery and radiation therapy
L-karnitinin etkisinin ne kadar srdne ynelik ise net bir veri bulunmuyor
Gastrointestinal side effects by dose level The most commonly reported side effects across the full dosing range include constipation , diarrhea , nausea, vomiting, and abdominal discomfort
#MyastheniaGravis #gMG #C5Inhibitor #Biopharma #Innovation #UCB #RareDisease #NextGenTherapy To view or add a comment, sign in FDA approves Boehringer Ingelheim's Nerandomilast, an oral PDE4B inhibitor for idiopathic pulmonary fibrosis treatment, marking the first new drug approved for the disease in over a decade To view or add a comment, sign in Great news and finally a new treatment option for IPF patients after a long time
